Re: Pareek A, Chandurkar N, Thomas N, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin 2014;30:1257-66

Curr Med Res Opin. 2015 Jun;31(6):1093-4. doi: 10.1185/03007995.2015.1035243.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Humans
  • Hydroxychloroquine / therapeutic use*
  • Hypoglycemic Agents / therapeutic use*
  • Male
  • Thiazolidinediones / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Hydroxychloroquine